{"podcast":{"title":"Touching Base","slug":"touching-base-6714887","podcast_index_feed_id":6714887,"rss_url":"https://feeds.acast.com/public/shows/65736d39d32e730012c98919","website_url":"https://shows.acast.com/65736d39d32e730012c98919","image_url":"https://assets.pippa.io/shows/cover/1702062363830-62d389f5db6a973569dc75512134cd32.jpeg","author":"Genetic Engineering & Biotechnology News (GEN)","episode_count":55,"summary":"Touching Base is the dynamic podcast series from the editors of GEN ( Genetic Engineering & Biotechnology News ). Each episode features a rotating cast of senior editors including John Sterling, Kevin Davies, Julianna LeMieux, Alex Philippidis, Uduak Thomas, Corinna Singleman and Fay Lin who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's now and next. Hosted on Acast. See acast.com/privacy for more information.","last_synced_at":"2026-08-01T02:20:08.667530+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887"},"episodes":[{"title":"Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors for Huntington’s","slug":"axiom-s-hong-kong-bet-latigo-s-positive-phase-ii-and-base-editors-for-huntington-s","published_at":"2026-07-31T13:54:01+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/axiom-s-hong-kong-bet-latigo-s-positive-phase-ii-and-base-editors-for-huntington-s","url":"https://shows.acast.com/touching-base/episodes/axioms-hong-kong-bet-latigos-positive-phase-ii-and-base-edit","duration_seconds":1936,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/axiom-s-hong-kong-bet-latigo-s-positive-phase-ii-and-base-editors-for-huntington-s/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/axiom-s-hong-kong-bet-latigo-s-positive-phase-ii-and-base-editors-for-huntington-s.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics","slug":"parkinson-s-in-the-clinic-insilico-enters-phase-iii-vertex-acquires-crinetics","published_at":"2026-07-17T01:51:51+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/parkinson-s-in-the-clinic-insilico-enters-phase-iii-vertex-acquires-crinetics","url":"https://shows.acast.com/touching-base/episodes/parkinsons-in-the-clinic-insilico-enters-phase-iii-vertex-ac","duration_seconds":1942,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/parkinson-s-in-the-clinic-insilico-enters-phase-iii-vertex-acquires-crinetics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/parkinson-s-in-the-clinic-insilico-enters-phase-iii-vertex-acquires-crinetics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Merck and Insilico Make Deals, Claude Science’s Debut, Vaccines for Neglected Diseases","slug":"merck-and-insilico-make-deals-claude-science-s-debut-vaccines-for-neglected-diseases","published_at":"2026-07-02T16:32:05+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/merck-and-insilico-make-deals-claude-science-s-debut-vaccines-for-neglected-diseases","url":"https://shows.acast.com/touching-base/episodes/merck-and-insilico-make-deals-claude-sciences-debut-vaccines","duration_seconds":2134,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/merck-and-insilico-make-deals-claude-science-s-debut-vaccines-for-neglected-diseases/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/merck-and-insilico-make-deals-claude-science-s-debut-vaccines-for-neglected-diseases.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Historic Biotech IPO, Merck, Protillion’s AI Deal, Testing a Lassa–Rabies Vaccine","slug":"historic-biotech-ipo-merck-protillion-s-ai-deal-testing-a-lassa-rabies-vaccine","published_at":"2026-06-18T17:14:57+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/historic-biotech-ipo-merck-protillion-s-ai-deal-testing-a-lassa-rabies-vaccine","url":"https://shows.acast.com/touching-base/episodes/historic-biotech-ipo-merck-protillions-ai-deal-testing-a-las","duration_seconds":2082,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/historic-biotech-ipo-merck-protillion-s-ai-deal-testing-a-lassa-rabies-vaccine/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/historic-biotech-ipo-merck-protillion-s-ai-deal-testing-a-lassa-rabies-vaccine.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"A Billion-Dollar Deal, Trial Trouble, Biohub Updates, and Vaccine Research News","slug":"a-billion-dollar-deal-trial-trouble-biohub-updates-and-vaccine-research-news","published_at":"2026-06-04T21:20:41+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/a-billion-dollar-deal-trial-trouble-biohub-updates-and-vaccine-research-news","url":"https://shows.acast.com/touching-base/episodes/a-billion-dollar-deal-trial-trouble-biohub-updates-and-vacci","duration_seconds":2241,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/a-billion-dollar-deal-trial-trouble-biohub-updates-and-vaccine-research-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/a-billion-dollar-deal-trial-trouble-biohub-updates-and-vaccine-research-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"AI Scientists, Stock Tumble, Patent Lawsuit, and New Partnerships","slug":"ai-scientists-stock-tumble-patent-lawsuit-and-new-partnerships","published_at":"2026-05-22T13:36:50+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/ai-scientists-stock-tumble-patent-lawsuit-and-new-partnerships","url":"https://shows.acast.com/touching-base/episodes/ai-scientists-stock-tumble-patent-lawsuit-and-new-partnershi","duration_seconds":1933,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/ai-scientists-stock-tumble-patent-lawsuit-and-new-partnerships/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/ai-scientists-stock-tumble-patent-lawsuit-and-new-partnerships.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Remembering J. Craig Venter, PhD","slug":"remembering-j-craig-venter-phd","published_at":"2026-05-07T17:39:32+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/remembering-j-craig-venter-phd","url":"https://shows.acast.com/touching-base/episodes/remembering-j-craig-venter-phd","duration_seconds":2631,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/remembering-j-craig-venter-phd/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/remembering-j-craig-venter-phd.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains","slug":"ai-in-oncology-takes-off-tackling-hiv-and-liver-disease-pharma-s-recent-gains","published_at":"2026-04-23T21:03:32+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/ai-in-oncology-takes-off-tackling-hiv-and-liver-disease-pharma-s-recent-gains","url":"https://shows.acast.com/touching-base/episodes/ai-in-oncology-takes-off-tackling-hiv-and-liver-disease-phar","duration_seconds":2003,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/ai-in-oncology-takes-off-tackling-hiv-and-liver-disease-pharma-s-recent-gains/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/ai-in-oncology-takes-off-tackling-hiv-and-liver-disease-pharma-s-recent-gains.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Drugs from a Text Prompt, Wegovy Pill Competition Dampens Lilly’s Surge","slug":"drugs-from-a-text-prompt-wegovy-pill-competition-dampens-lilly-s-surge","published_at":"2026-04-09T19:57:54+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/drugs-from-a-text-prompt-wegovy-pill-competition-dampens-lilly-s-surge","url":"https://shows.acast.com/touching-base/episodes/drugs-from-a-text-prompt-wegovy-pill-competition-dampens-lil","duration_seconds":1909,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/drugs-from-a-text-prompt-wegovy-pill-competition-dampens-lilly-s-surge/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/drugs-from-a-text-prompt-wegovy-pill-competition-dampens-lilly-s-surge.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Agentic AI, Virtual Cell, LNP Vaccine Boosters, Engineered Organs, and Mergers","slug":"agentic-ai-virtual-cell-lnp-vaccine-boosters-engineered-organs-and-mergers","published_at":"2026-03-26T19:41:46+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/agentic-ai-virtual-cell-lnp-vaccine-boosters-engineered-organs-and-mergers","url":"https://shows.acast.com/touching-base/episodes/agentic-ai-virtual-cell-lnp-vaccine-boosters-engineered-orga","duration_seconds":2383,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/agentic-ai-virtual-cell-lnp-vaccine-boosters-engineered-organs-and-mergers/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/agentic-ai-virtual-cell-lnp-vaccine-boosters-engineered-organs-and-mergers.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Bacteria 4D Simulation, Safer Large Gene Insertion, uniQure Roller Coaster","slug":"bacteria-4d-simulation-safer-large-gene-insertion-uniqure-roller-coaster","published_at":"2026-03-13T01:12:28+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/bacteria-4d-simulation-safer-large-gene-insertion-uniqure-roller-coaster","url":"https://shows.acast.com/touching-base/episodes/bacteria-4d-simulation-safer-large-gene-insertion-uniqure-ro","duration_seconds":2462,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/bacteria-4d-simulation-safer-large-gene-insertion-uniqure-roller-coaster/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/bacteria-4d-simulation-safer-large-gene-insertion-uniqure-roller-coaster.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"AI for Scientists, FDA Reverses Course, and Advances in Cancer Therapeutics","slug":"ai-for-scientists-fda-reverses-course-and-advances-in-cancer-therapeutics","published_at":"2026-02-27T14:18:15+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/ai-for-scientists-fda-reverses-course-and-advances-in-cancer-therapeutics","url":"https://shows.acast.com/touching-base/episodes/ai-for-scientists-fda-reverses-course-and-advances-in-cancer","duration_seconds":2334,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/ai-for-scientists-fda-reverses-course-and-advances-in-cancer-therapeutics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/ai-for-scientists-fda-reverses-course-and-advances-in-cancer-therapeutics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Women in Science, Robotics, Automation, SLAS, and Lilly Updates","slug":"women-in-science-robotics-automation-slas-and-lilly-updates","published_at":"2026-02-13T13:27:10+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/women-in-science-robotics-automation-slas-and-lilly-updates","url":"https://shows.acast.com/touching-base/episodes/women-in-science-robotics-automation-slas-and-lilly-updates","duration_seconds":1964,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/women-in-science-robotics-automation-slas-and-lilly-updates/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/women-in-science-robotics-automation-slas-and-lilly-updates.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Ex-CEO Behind Bars, 10x’s Clinical Ambitions, and Pharma’s AI Gambit","slug":"ex-ceo-behind-bars-10x-s-clinical-ambitions-and-pharma-s-ai-gambit","published_at":"2026-01-30T14:33:06+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/ex-ceo-behind-bars-10x-s-clinical-ambitions-and-pharma-s-ai-gambit","url":"https://shows.acast.com/touching-base/episodes/ex-ceo-behind-bars-10xs-clinical-ambitions-and-pharmas-ai-ga","duration_seconds":2057,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/ex-ceo-behind-bars-10x-s-clinical-ambitions-and-pharma-s-ai-gambit/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/ex-ceo-behind-bars-10x-s-clinical-ambitions-and-pharma-s-ai-gambit.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Editors’ Choice: Top Stories of 2025","slug":"editors-choice-top-stories-of-2025","published_at":"2025-12-18T18:12:44+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/editors-choice-top-stories-of-2025","url":"https://shows.acast.com/touching-base/episodes/editors-choice-top-stories-of-2025","duration_seconds":2460,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/editors-choice-top-stories-of-2025/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/editors-choice-top-stories-of-2025.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Lung Organoids, Autism and Sarcopenia Insights in Mice, and a Bidding War Ends","slug":"lung-organoids-autism-and-sarcopenia-insights-in-mice-and-a-bidding-war-ends","published_at":"2025-12-04T22:27:26+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/lung-organoids-autism-and-sarcopenia-insights-in-mice-and-a-bidding-war-ends","url":"https://shows.acast.com/touching-base/episodes/lung-organoids-autism-and-sarcopenia-insights-in-mice-and-a","duration_seconds":2156,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/lung-organoids-autism-and-sarcopenia-insights-in-mice-and-a-bidding-war-ends/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/lung-organoids-autism-and-sarcopenia-insights-in-mice-and-a-bidding-war-ends.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"New Nasal Vaccines, Korro Stock Dips, J&J and Merck Acquisitions, and Dyno GATC","slug":"new-nasal-vaccines-korro-stock-dips-j-j-and-merck-acquisitions-and-dyno-gatc","published_at":"2025-11-20T22:01:42+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/new-nasal-vaccines-korro-stock-dips-j-j-and-merck-acquisitions-and-dyno-gatc","url":"https://shows.acast.com/touching-base/episodes/new-nasal-vaccines-korro-stock-dips-jj-and-merck-acquisition","duration_seconds":2510,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/new-nasal-vaccines-korro-stock-dips-j-j-and-merck-acquisitions-and-dyno-gatc/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/new-nasal-vaccines-korro-stock-dips-j-j-and-merck-acquisitions-and-dyno-gatc.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"uniQure Staggers at FDA, Recursion's Microglia Map, and Leadership Transitions","slug":"uniqure-staggers-at-fda-recursion-s-microglia-map-and-leadership-transitions","published_at":"2025-11-07T16:06:18+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/uniqure-staggers-at-fda-recursion-s-microglia-map-and-leadership-transitions","url":"https://shows.acast.com/touching-base/episodes/uniqure-staggers-at-fda-recursions-microglia-map-and-leaders","duration_seconds":1894,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/uniqure-staggers-at-fda-recursion-s-microglia-map-and-leadership-transitions/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/uniqure-staggers-at-fda-recursion-s-microglia-map-and-leadership-transitions.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Artificial Intelligence in the Emerald City and Targeting Colon Cancer Stem Cells","slug":"artificial-intelligence-in-the-emerald-city-and-targeting-colon-cancer-stem-cells","published_at":"2025-10-24T15:21:09+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/artificial-intelligence-in-the-emerald-city-and-targeting-colon-cancer-stem-cells","url":"https://shows.acast.com/touching-base/episodes/artificial-intelligence-in-the-emerald-city-and-targeting-co","duration_seconds":1468,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/artificial-intelligence-in-the-emerald-city-and-targeting-colon-cancer-stem-cells/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/artificial-intelligence-in-the-emerald-city-and-targeting-colon-cancer-stem-cells.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Nobel Prizes Announced and Breakthroughs for Huntington’s and Rare Diseases","slug":"nobel-prizes-announced-and-breakthroughs-for-huntington-s-and-rare-diseases","published_at":"2025-10-10T13:16:41+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/nobel-prizes-announced-and-breakthroughs-for-huntington-s-and-rare-diseases","url":"https://shows.acast.com/touching-base/episodes/nobel-prizes-announced-and-breakthroughs-for-huntingtons-and","duration_seconds":1260,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/nobel-prizes-announced-and-breakthroughs-for-huntington-s-and-rare-diseases/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/nobel-prizes-announced-and-breakthroughs-for-huntington-s-and-rare-diseases.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"BPI 2025 Debrief and Takeaways","slug":"bpi-2025-debrief-and-takeaways","published_at":"2025-09-26T15:31:32+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/bpi-2025-debrief-and-takeaways","url":"https://shows.acast.com/touching-base/episodes/bpi-2025-debrief-and-takeaways","duration_seconds":1697,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/bpi-2025-debrief-and-takeaways/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/bpi-2025-debrief-and-takeaways.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Developing New Therapies Through Partnership, Electricity, and Immunotherapy","slug":"developing-new-therapies-through-partnership-electricity-and-immunotherapy","published_at":"2025-09-05T13:50:09+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/developing-new-therapies-through-partnership-electricity-and-immunotherapy","url":"https://shows.acast.com/touching-base/episodes/developing-new-therapies-through-partnership-electricity-and","duration_seconds":1650,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/developing-new-therapies-through-partnership-electricity-and-immunotherapy/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/developing-new-therapies-through-partnership-electricity-and-immunotherapy.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Stem Cells in Space and AI for Nanoparticles and Peptide Design","slug":"stem-cells-in-space-and-ai-for-nanoparticles-and-peptide-design","published_at":"2025-08-22T14:35:18+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/stem-cells-in-space-and-ai-for-nanoparticles-and-peptide-design","url":"https://shows.acast.com/touching-base/episodes/stem-cells-in-space-and-ai-for-nanoparticles-and-peptide-des","duration_seconds":1294,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/stem-cells-in-space-and-ai-for-nanoparticles-and-peptide-design/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/stem-cells-in-space-and-ai-for-nanoparticles-and-peptide-design.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Reversing Parkinson’s in Mice, Protecting Primates from HIV, Top 10 Biotech Clusters, and Sarepta","slug":"reversing-parkinson-s-in-mice-protecting-primates-from-hiv-top-10-biotech-clusters-and-sarepta","published_at":"2025-08-08T16:15:01+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/reversing-parkinson-s-in-mice-protecting-primates-from-hiv-top-10-biotech-clusters-and-sarepta","url":"https://shows.acast.com/touching-base/episodes/reversing-parkinsons-in-mice-protecting-primates-from-hiv-to","duration_seconds":2062,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/reversing-parkinson-s-in-mice-protecting-primates-from-hiv-top-10-biotech-clusters-and-sarepta/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/reversing-parkinson-s-in-mice-protecting-primates-from-hiv-top-10-biotech-clusters-and-sarepta.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Sarepta Under Scrutiny, AstraZeneca’s Big Bet, and AI vs. IDRs","slug":"sarepta-under-scrutiny-astrazeneca-s-big-bet-and-ai-vs-idrs","published_at":"2025-07-25T02:32:43+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/sarepta-under-scrutiny-astrazeneca-s-big-bet-and-ai-vs-idrs","url":"https://shows.acast.com/touching-base/episodes/sarepta-under-scrutiny-astrazenecas-big-bet-and-ai-vs-idrs","duration_seconds":2554,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/sarepta-under-scrutiny-astrazeneca-s-big-bet-and-ai-vs-idrs/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/sarepta-under-scrutiny-astrazeneca-s-big-bet-and-ai-vs-idrs.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Merck Acquires Verona, Virtual Cell Challenge, Gene Therapy Restores Hearing","slug":"merck-acquires-verona-virtual-cell-challenge-gene-therapy-restores-hearing","published_at":"2025-07-11T13:05:17+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/merck-acquires-verona-virtual-cell-challenge-gene-therapy-restores-hearing","url":"https://shows.acast.com/touching-base/episodes/merck-acquires-verona-virtual-cell-challenge-gene-therapy-re","duration_seconds":1901,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/merck-acquires-verona-virtual-cell-challenge-gene-therapy-restores-hearing/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/merck-acquires-verona-virtual-cell-challenge-gene-therapy-restores-hearing.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"BIO 2025, Huge Virtual Cell Dataset, AI-Designed De Novo Proteins","slug":"bio-2025-huge-virtual-cell-dataset-ai-designed-de-novo-proteins","published_at":"2025-06-18T19:59:45+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/bio-2025-huge-virtual-cell-dataset-ai-designed-de-novo-proteins","url":"https://shows.acast.com/touching-base/episodes/bio-2025-huge-virtual-cell-dataset-ai-designed-de-novo-prote","duration_seconds":1724,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/bio-2025-huge-virtual-cell-dataset-ai-designed-de-novo-proteins/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/bio-2025-huge-virtual-cell-dataset-ai-designed-de-novo-proteins.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Rocket’s Gene Therapy Trial Paused, Boltz-2 Open Source, Plasma Swap Rewinds Aging","slug":"rocket-s-gene-therapy-trial-paused-boltz-2-open-source-plasma-swap-rewinds-aging","published_at":"2025-06-06T13:14:10+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/rocket-s-gene-therapy-trial-paused-boltz-2-open-source-plasma-swap-rewinds-aging","url":"https://shows.acast.com/touching-base/episodes/rockets-gene-therapy-trial-paused-boltz-2-open-source-plasma","duration_seconds":1795,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/rocket-s-gene-therapy-trial-paused-boltz-2-open-source-plasma-swap-rewinds-aging/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/rocket-s-gene-therapy-trial-paused-boltz-2-open-source-plasma-swap-rewinds-aging.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Customized CRISPR for KJ, 10x and Illumina Lawsuits, Regeneron Bags 23andMe","slug":"customized-crispr-for-kj-10x-and-illumina-lawsuits-regeneron-bags-23andme","published_at":"2025-05-22T16:38:20+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/customized-crispr-for-kj-10x-and-illumina-lawsuits-regeneron-bags-23andme","url":"https://shows.acast.com/touching-base/episodes/customized-crispr-for-kj-10x-and-illumina-lawsuits-regeneron","duration_seconds":2494,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/customized-crispr-for-kj-10x-and-illumina-lawsuits-regeneron-bags-23andme/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/customized-crispr-for-kj-10x-and-illumina-lawsuits-regeneron-bags-23andme.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Insights into COVID-19’s Origins, Recursion Reverses Course, and AACR Stands Up for Cancer Research","slug":"insights-into-covid-19-s-origins-recursion-reverses-course-and-aacr-stands-up-for-cancer-research","published_at":"2025-05-09T16:27:51+00:00","page_url":"https://stenobird.com/podcast/touching-base-6714887/insights-into-covid-19-s-origins-recursion-reverses-course-and-aacr-stands-up-for-cancer-research","url":"https://shows.acast.com/touching-base/episodes/insights-into-covid-19s-origins-recursion-reverses-course-an","duration_seconds":2134,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/touching-base-6714887/episodes/insights-into-covid-19-s-origins-recursion-reverses-course-and-aacr-stands-up-for-cancer-research/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/touching-base-6714887/insights-into-covid-19-s-origins-recursion-reverses-course-and-aacr-stands-up-for-cancer-research.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}]}